# Study of TNF-Antagonism in the Metabolic Syndrome (II)

> **NCT00413400** · NA · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 40 (actual)

## Conditions studied

- Metabolic Syndrome

## Interventions

- **DRUG:** Etanercept
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00413400
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-12
- **Primary completion:** 2009-09
- **Final completion:** 2009-09
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2010-12-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00413400

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00413400, "Study of TNF-Antagonism in the Metabolic Syndrome (II)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00413400. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*